Earkart Ltd. · BSE:EARKART
Earkart — H1FY26 Earnings Presentation
23 slides from Earkart's earnings presentation, Nov 24, 2025
Slide 1: Investor Presentation cover letter to BSE
EARKART LIMITED (formerly known as Earkart Private Limited) CIN: L74999DL2021PLC399313 www.earkart.in info@earkart.in To, BSE Surveillance, BSE Limited P J Towers, Dalal Street, Mumbai -400001, India Subject: Investor Presentation Dear Sir/Madam, Pursuant to Regulation 30 of SEBI (Listing Obligation
Slide 2: Investor Presentation H1FY26
www.earkart.in Investor Presentation H1FY26
Slide 3: Disclaimer
Redefining Hearing Care Disclaimer This presentation (the “Presentation”) has been prepared by Earkart Ltd (“the Company”) solely for informational purposes. It does not constitute an offer, recommendation, or invitation to purchase or subscribe for any securities, and should not be relied upon in c
Slide 4: Company Overview
Redefining Hearing Care Company Overview Earkart Limited is a tech-driven hearing healthcare company focused on affordable, quality hearing aids for India. 3 Brands 69% Revenue From Manufacturing Area EQFY, Fame, Radius Government and 29% 4,500 Sq. Ft. Revenue From Private The company offers a wide
Slide 5: Our Journey
Redefining Hearing Care Our Journey BIS license received Launch of ENT (Shop in Shop Model) Received First Government order for Launch of remote video Audiometry Device OMNI 10,000 Hearing Aids units Conversion into a Public Limited Company 2021 2022 2023 2024 2025 Received ISO 13485:2016 certificat
Slide 6: Management Profile
Redefining Hearing Care Management Profile Mr. Rohit Mishra Ms. Monika Mishra Promoter & Managing Director Promoter & Whole- Time Director Experience: 30+ Years Experience: 25+ years Holds B.Sc. (Meerut University) & Diploma in Holds B.Sc. (1993) & M.Sc. (1995) from Meerut Qualification: Qualificati
Slide 7: Manufacturing Facility
Redefining Hearing Care Manufacturing Facility Team & Technology Capabilities Dedicated team of 6+ skilled employees End-to-end production: MIC component processing, Equipped with advanced machinery receiver integration, BTE assembly Location: (micro soldering, stereoscope, barcode printers, etc.) I
Slide 8: Certifications
Redefining Hearing Care Certifications Post Post Approval Approval BIS Certified (Bureau of Indian FileFile No No : MD/PostAppr/2025/34163 : MD/PostAppr/2025/34163 FoodFood And And DrugDrug Administration, Administration, UttarUttar Pradesh, Pradesh, Date:Date: 30-May-2025 30-May-2025 Standards) To
Slide 9: Testing Infrastructure
Redefining Hearing Care Testing Infrastructure Hearing Aid Digital Micrometer Digital Weighing Heating Chamber Analyzer & Vernier Caliper Balance Frequency range 200–8,000 Hz Precision dimensional checks Accuracy up to 0.01g For drying and stress-testing components.
Slide 10: Business Model
Business Model Shop-in-Shop (SIS) Model Private Business Own brands EQFY, Fame, Radius alongside third-party accessories and rehabilitative products. Distribution through retailers, Clinics set up in ENT & optical centers across Tier 2/3 cities wholesalers, and direct sales, 49 SIS clinics operation
Slide 11: Product Portfolio
Redefining Hearing Care Product Portfolio Brands: EQFY, Fame, Radius BRANDS Range: Behind-the-Ear (BTE) and Receiver-in-Canal (RIC) models Features: Digital, programmable, rechargeable, and Bluetooth-enabled for seamless connectivity Positioning: Designed for affordability and accessibility, especia
Slide 12: Service Offerings
Redefining Hearing Care Service Offerings Conversion Consultancy Audiometry Franchise Charges Services Charges Fees Earned when leads convert Lead generation via digital Income from diagnostic Fees from ENT & Ophthalmic to confirmed hearing aid platforms (Google, Meta, tests conducted at SIS clinics
Slide 13: Earkart OMNI Audiometer
Redefining Hearing Care Earkart OMNI Audiometer Over 60% of India’s population, Traditional models require each especially in Tier 2/3 cities and patient to visit a local audiologist rural areas, have no access to —making access nearly audiology services. impossible for most. India has just 63 milli
Slide 14: Earkart OMNI Audiometer
Redefining Hearing Care Earkart OMNI Audiometer Overview This disrupts scarcity, bringing last-mile hearing care to unserved cities and towns, and has been met with overwhelming demand in India and internationally. Diagnostic Capabilities Remote-operated audiometer enabling hearing loss diagnosis &
Slide 15: Revenue Bifurcation and Geographical Presence
Redefining Hearing Care Revenue Bifurcation Geographical Presence Particulars FY23 FY24 FY25 Customer Presence Exports To across 17 States 4 countries Domestic 2,774.07 3,083.00 4,205.28 Exports 2.28 10.83 34.10 Total 2,776.36 3,093.83 4,239.38 Gujarat Others 2.2% 2.5% Delhi 15.5% Maharashtra 2.4% R
Slide 16: Industry Overview
Redefining Hearing Care Industry Overview The global hearing aid market, valued at $8.1B in 2023, is projected to grow at a 6.6% CAGR to reach $12.67B by 2030. About 430M people (~5% of the global population) need hearing rehabilitation, with 66.5% aged 60+, Key Growth Drivers 25.6% aged 15–59, and
Slide 17: Earkart Breaks New Ground with Patent Approval
Earkart Breaks New Ground with Patent Approval We’re thrilled to announce that Earkart’s patent for the “Smart Sound Treatment and Diagnosis System, and Method Thereof” has been officially granted under The Patents Act, 1970—cementing our leadership in next-gen audiology for the next 20 years. What
Slide 18: Earkart at World's Largest ENT Conference
Earkart at World’s Largest ENT Conference Global Event Presence Innovation & Engagement Earkart participated in the world’s largest otolaryngology Showcased OMNI, Earkart’s remote diagnostic platform, at conference in Indianapolis, USA, from October 11–13, 2025. the world’s largest ENT and audiology
Slide 19: Future Growth & Expansion Plans
Future Growth & Expansion Plans Innovation & Technology Edge Cutting-edge R&D and proprietary tech. Earkart OMNI: Remote testing, tele-audiology, CRM- ready. Superior patient experience, scalable and cost- efficient. Multi-Channel Distribution Online: Earkart website & top aggregators. Offline: Wide
Slide 20: Profit & Loss
Redefining Hearing Care Profit & Loss (₹ in Lakhs except EPS) Particulars H1FY26 H1FY25 YoY% Revenue from Operations 2228.57 2354.98 (5.37%) Other Income 2.44 6.47 (62.29%) Total Income 2231.01 2361.45 (5.52%) Total Expenditure 1915.22 1859.64 2.99% EBITDA 315.79 501.81 (37.07%) EBITDA Margin 14.17%
Slide 21: Balance Sheet
Redefining Hearing Care Balance Sheet (₹ in Lakhs) Particulars As at September 30,2025 As at March 31,2025 Share Capital 1375.39 1043.89 Reserves 5230.75 947.77 Short Term Borrowings 561.75 495.93 Trade Payables 427.58 301.67 Current Liabilities 222.73 240.12 Total Liabilities 7818.20 3029.38 Fixed
Slide 22: Addressing H1 Performance & Driving H2 Upside
Addressing H1 Performance & Driving H2 Upside Revenue Dip Due to Order Deferral Operational Scale-Up Costs Investments Enabling Future Scale Government orders that were Increased operational scale during The increase in operational costs scheduled for the first half were expansion led to higher manp
Slide 23: THANK YOU
THANK YOU Preeti Srivastava Abhishek Bhutra | Himanshu Jain Company Secretary +91 80006 85556 , +91 89051 81853 ir@earkart.in ir@finportalin.com Meeting Request Link